Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and potential efficacy of the armored CAR-T cell therapy C-CAR031 in advanced hepatocellular carcinoma is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• C-CAR031 Armored CAR-T Cell (C-CAR031)

Snippet

Sponsor: Zhejiang University | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING